284 related articles for article (PubMed ID: 19017592)
21. Meta-analysis of major depressive disorder relapse and recurrence with second-generation antidepressants.
Hansen R; Gaynes B; Thieda P; Gartlehner G; Deveaugh-Geiss A; Krebs E; Lohr K
Psychiatr Serv; 2008 Oct; 59(10):1121-30. PubMed ID: 18832497
[TBL] [Abstract][Full Text] [Related]
22. Treatment of depression--newer pharmacotherapies.
Mulrow CD; Williams JW; Trivedi M; Chiquette E; Aguilar C; Cornell JE; Badgett R; Noël PH; Lawrence V; Lee S; Luther M; Ramirez G; Richardson WS; Stamm K
Psychopharmacol Bull; 1998; 34(4):409-795. PubMed ID: 10513454
[TBL] [Abstract][Full Text] [Related]
23. [Clinical efficacy and achievement of a complete remission in depression: increasing interest in treatment with escitalopram].
Favré P
Encephale; 2012 Feb; 38(1):86-96. PubMed ID: 22381728
[TBL] [Abstract][Full Text] [Related]
24. Network Meta-Analysis and Cost-Effectiveness Analysis of New Generation Antidepressants.
Khoo AL; Zhou HJ; Teng M; Lin L; Zhao YJ; Soh LB; Mok YM; Lim BP; Gwee KP
CNS Drugs; 2015 Aug; 29(8):695-712. PubMed ID: 26293743
[TBL] [Abstract][Full Text] [Related]
25. Antidepressants for the treatment of adults with major depressive disorder in the maintenance phase: a systematic review and network meta-analysis.
Kishi T; Ikuta T; Sakuma K; Okuya M; Hatano M; Matsuda Y; Iwata N
Mol Psychiatry; 2023 Jan; 28(1):402-409. PubMed ID: 36253442
[TBL] [Abstract][Full Text] [Related]
26. Efficacy of antidepressants for late-life depression: a meta-analysis and meta-regression of placebo-controlled randomized trials.
Tedeschini E; Levkovitz Y; Iovieno N; Ameral VE; Nelson JC; Papakostas GI
J Clin Psychiatry; 2011 Dec; 72(12):1660-8. PubMed ID: 22244025
[TBL] [Abstract][Full Text] [Related]
27. Systematic review and meta-analysis of second-generation antidepressants for the treatment of older adults with depression: questionable benefit and considerations for frailty.
Mallery L; MacLeod T; Allen M; McLean-Veysey P; Rodney-Cail N; Bezanson E; Steeves B; LeBlanc C; Moorhouse P
BMC Geriatr; 2019 Nov; 19(1):306. PubMed ID: 31718566
[TBL] [Abstract][Full Text] [Related]
28. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis.
Amick HR; Gartlehner G; Gaynes BN; Forneris C; Asher GN; Morgan LC; Coker-Schwimmer E; Boland E; Lux LJ; Gaylord S; Bann C; Pierl CB; Lohr KN
BMJ; 2015 Dec; 351():h6019. PubMed ID: 26645251
[TBL] [Abstract][Full Text] [Related]
29. Nonpharmacologic and Pharmacologic Treatments of Adult Patients With Major Depressive Disorder: A Systematic Review and Network Meta-analysis for a Clinical Guideline by the American College of Physicians.
Gartlehner G; Dobrescu A; Chapman A; Toromanova A; Emprechtinger R; Persad E; Affengruber L; Pieh C; Klerings I; Wagner G
Ann Intern Med; 2023 Feb; 176(2):196-211. PubMed ID: 36689750
[TBL] [Abstract][Full Text] [Related]
30. Efficacy and tolerability of second-generation antidepressants in social anxiety disorder.
Hansen RA; Gaynes BN; Gartlehner G; Moore CG; Tiwari R; Lohr KN
Int Clin Psychopharmacol; 2008 May; 23(3):170-9. PubMed ID: 18408531
[TBL] [Abstract][Full Text] [Related]
31. Beneficial and harmful effects of antidepressants versus placebo, 'active placebo', or no intervention for adults with major depressive disorder: a protocol for a systematic review of published and unpublished data with meta-analyses and trial sequential analyses.
Juul S; Siddiqui F; Barbateskovic M; Jørgensen CK; Hengartner MP; Kirsch I; Gluud C; Jakobsen JC
Syst Rev; 2021 May; 10(1):154. PubMed ID: 34034811
[TBL] [Abstract][Full Text] [Related]
32. Side effect profile and comparative tolerability of 21 antidepressants in the acute treatment of major depression in adults: protocol for a network meta-analysis.
Tomlinson A; Efthimiou O; Boaden K; New E; Mather S; Salanti G; Imai H; Ogawa Y; Tajika A; Kishimoto S; Kikuchi S; Chevance A; Furukawa TA; Cipriani A
Evid Based Ment Health; 2019 May; 22(2):61-66. PubMed ID: 30996028
[TBL] [Abstract][Full Text] [Related]
33. Smoking cessation interventions for smokers with current or past depression.
van der Meer RM; Willemsen MC; Smit F; Cuijpers P
Cochrane Database Syst Rev; 2013 Aug; (8):CD006102. PubMed ID: 23963776
[TBL] [Abstract][Full Text] [Related]
34. Escitalopram: a pharmacoeconomic review of its use in depression.
Croom KF; Plosker GL
Pharmacoeconomics; 2003; 21(16):1185-209. PubMed ID: 14594439
[TBL] [Abstract][Full Text] [Related]
35. Evidence synthesis, practice guidelines and real-world prescriptions of new generation antidepressants in the treatment of depression: a protocol for cumulative network meta-analyses and meta-epidemiological study.
Luo Y; Chaimani A; Kataoka Y; Ostinelli EG; Ogawa Y; Cipriani A; Salanti G; Furukawa TA
BMJ Open; 2018 Dec; 8(12):e023222. PubMed ID: 30530583
[TBL] [Abstract][Full Text] [Related]
36.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
37.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
